Philips (NYSE:PHG) has no plans for an offer to counter German rival Siemens Healthineers’ (OTCPK:SMMNY) bid for Corindus Vascular Robotics.
Healthineers said last week that it had reached an agreement to buy Corindus, which develops robotic systems for minimally invasive vascular therapy procedures, for $1.1B.
Philips is the second-largest shareholder in Corindus with a 12.8% stake, according to Refinitiv data.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.